drugset / Trial / NCT00380211
Safety and Immunogenicity of FluLaval™ TR and Fluarix® (Influenza Vaccines) in Young and Older Adults
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this trial is to describe the immunogenicity, the safety, and tolerability of FluLaval™ TR and Fluarix®, the latter serving as active comparator. The results will be compared to a standard immune response criteria, for both young and elderly populations.
Timeline
- Start
- 2006-09
- Primary completion
- —
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FluLaval™ TR | Vaccine | — | — |
| Subject | Influenza Virus Vaccine | Vaccine | — | — |